Cargando…

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity

In this study, we aimed to develop a pharmacophore-based three-dimensional quantitative structure activity relationship (3D-QSAR) for a set including sixty-two cytotoxic quinolines (1-62) as anticancer agents with tubulin inhibitory activity. A total of 279 pharmacophore hypotheses were generated ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzaei, Salimeh, Ghodsi, Razieh, Hadizadeh, Farzin, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410400/
https://www.ncbi.nlm.nih.gov/pubmed/34485522
http://dx.doi.org/10.1155/2021/6480804
_version_ 1783747112969699328
author Mirzaei, Salimeh
Ghodsi, Razieh
Hadizadeh, Farzin
Sahebkar, Amirhossein
author_facet Mirzaei, Salimeh
Ghodsi, Razieh
Hadizadeh, Farzin
Sahebkar, Amirhossein
author_sort Mirzaei, Salimeh
collection PubMed
description In this study, we aimed to develop a pharmacophore-based three-dimensional quantitative structure activity relationship (3D-QSAR) for a set including sixty-two cytotoxic quinolines (1-62) as anticancer agents with tubulin inhibitory activity. A total of 279 pharmacophore hypotheses were generated based on the survival score to build QSAR models. A six-point pharmacophore model (AAARRR.1061) was identified as the best model which consisted of three hydrogen bond acceptors (A) and three aromatic ring (R) features. The model showed a high correlation coefficient (R(2) = 0.865), cross-validation coefficient (Q(2) = 0.718), and F value (72.3). The best pharmacophore model was then validated by the Y-Randomization test and ROC-AUC analysis. The generated 3D contour maps were used to reveal the structure activity relationship of the compounds. The IBScreen database was screened against AAARRR.1061, and after calculating ADMET properties, 10 compounds were selected for further docking study. Molecular docking analysis showed that compound STOCK2S-23597 with the highest docking score (-10.948 kcal/mol) had hydrophobic interactions and can form four hydrogen bonds with active site residues.
format Online
Article
Text
id pubmed-8410400
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84104002021-09-02 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity Mirzaei, Salimeh Ghodsi, Razieh Hadizadeh, Farzin Sahebkar, Amirhossein Biomed Res Int Research Article In this study, we aimed to develop a pharmacophore-based three-dimensional quantitative structure activity relationship (3D-QSAR) for a set including sixty-two cytotoxic quinolines (1-62) as anticancer agents with tubulin inhibitory activity. A total of 279 pharmacophore hypotheses were generated based on the survival score to build QSAR models. A six-point pharmacophore model (AAARRR.1061) was identified as the best model which consisted of three hydrogen bond acceptors (A) and three aromatic ring (R) features. The model showed a high correlation coefficient (R(2) = 0.865), cross-validation coefficient (Q(2) = 0.718), and F value (72.3). The best pharmacophore model was then validated by the Y-Randomization test and ROC-AUC analysis. The generated 3D contour maps were used to reveal the structure activity relationship of the compounds. The IBScreen database was screened against AAARRR.1061, and after calculating ADMET properties, 10 compounds were selected for further docking study. Molecular docking analysis showed that compound STOCK2S-23597 with the highest docking score (-10.948 kcal/mol) had hydrophobic interactions and can form four hydrogen bonds with active site residues. Hindawi 2021-08-24 /pmc/articles/PMC8410400/ /pubmed/34485522 http://dx.doi.org/10.1155/2021/6480804 Text en Copyright © 2021 Salimeh Mirzaei et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mirzaei, Salimeh
Ghodsi, Razieh
Hadizadeh, Farzin
Sahebkar, Amirhossein
3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
title 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
title_full 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
title_fullStr 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
title_full_unstemmed 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
title_short 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
title_sort 3d-qsar-based pharmacophore modeling, virtual screening, and molecular docking studies for identification of tubulin inhibitors with potential anticancer activity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410400/
https://www.ncbi.nlm.nih.gov/pubmed/34485522
http://dx.doi.org/10.1155/2021/6480804
work_keys_str_mv AT mirzaeisalimeh 3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity
AT ghodsirazieh 3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity
AT hadizadehfarzin 3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity
AT sahebkaramirhossein 3dqsarbasedpharmacophoremodelingvirtualscreeningandmoleculardockingstudiesforidentificationoftubulininhibitorswithpotentialanticanceractivity